rs11601239

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000829.4(GRIA4):​c.248-67109C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.48 in 151,508 control chromosomes in the GnomAD database, including 18,128 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.48 ( 18128 hom., cov: 30)

Consequence

GRIA4
NM_000829.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.552

Publications

11 publications found
Variant links:
Genes affected
GRIA4 (HGNC:4574): (glutamate ionotropic receptor AMPA type subunit 4) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing of this gene results in transcript variants encoding different isoforms, which may vary in their signal transduction properties. Some haplotypes of this gene show a positive association with schizophrenia. [provided by RefSeq, Jul 2008]
GRIA4 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with or without seizures and gait abnormalities
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Illumina, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.574 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000829.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIA4
NM_000829.4
MANE Select
c.248-67109C>G
intron
N/ANP_000820.4
GRIA4
NM_001440382.1
c.248-67109C>G
intron
N/ANP_001427311.1
GRIA4
NM_001440383.1
c.248-67109C>G
intron
N/ANP_001427312.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIA4
ENST00000282499.10
TSL:5 MANE Select
c.248-67109C>G
intron
N/AENSP00000282499.5
GRIA4
ENST00000530497.1
TSL:1
c.248-67109C>G
intron
N/AENSP00000435775.1
GRIA4
ENST00000525187.6
TSL:1
c.248-67109C>G
intron
N/AENSP00000432180.1

Frequencies

GnomAD3 genomes
AF:
0.480
AC:
72734
AN:
151390
Hom.:
18124
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.335
Gnomad AMI
AF:
0.447
Gnomad AMR
AF:
0.584
Gnomad ASJ
AF:
0.532
Gnomad EAS
AF:
0.385
Gnomad SAS
AF:
0.462
Gnomad FIN
AF:
0.594
Gnomad MID
AF:
0.522
Gnomad NFE
AF:
0.534
Gnomad OTH
AF:
0.483
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.480
AC:
72755
AN:
151508
Hom.:
18128
Cov.:
30
AF XY:
0.486
AC XY:
35932
AN XY:
73976
show subpopulations
African (AFR)
AF:
0.335
AC:
13820
AN:
41238
American (AMR)
AF:
0.584
AC:
8872
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
0.532
AC:
1841
AN:
3462
East Asian (EAS)
AF:
0.385
AC:
1975
AN:
5134
South Asian (SAS)
AF:
0.463
AC:
2228
AN:
4808
European-Finnish (FIN)
AF:
0.594
AC:
6220
AN:
10464
Middle Eastern (MID)
AF:
0.503
AC:
146
AN:
290
European-Non Finnish (NFE)
AF:
0.534
AC:
36238
AN:
67904
Other (OTH)
AF:
0.480
AC:
1008
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1824
3649
5473
7298
9122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
660
1320
1980
2640
3300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.377
Hom.:
1103
Bravo
AF:
0.478
Asia WGS
AF:
0.419
AC:
1458
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.16
DANN
Benign
0.36
PhyloP100
-0.55
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11601239; hg19: chr11-105556598; API